Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://sidneyxbjv066518.articlesblogger.com/61342139/semaglutide-a-potential-solution-for-metabolic-disorders